Evidence map›Paper›PMID 35602350›Full record

ArticleComputational and mathematical methods in medicine2022

The Levels of TNF-

Xuan Ma, Xue-E Wang, Lin-Xia Xie, Sha Lu, Cheng Jiang

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Retracted: The Levels of TNF-Computational and mathematical methods in medicine · 2023
    Article
4 · The record

Corrections and comments

  • Retraction · 2023-06-28Concerns/Issues about Data · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Unreliable Results and/or Conclusions ·
  • Retracted
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xuan MaDepartment of Respiratory Medicine, Xi'an International Medical Center Hospital, Xi'an, 710100 Shaanxi, China.
Xue-E WangDepartment of Respiratory Medicine, Xi'an International Medical Center Hospital, Xi'an, 710100 Shaanxi, China.
Lin-Xia XieDepartment of Respiratory Medicine, Xi'an International Medical Center Hospital, Xi'an, 710100 Shaanxi, China.
Sha LuDepartment of Respiratory Medicine, Xi'an International Medical Center Hospital, Xi'an, 710100 Shaanxi, China.
Cheng JiangDepartment of Pulmonary and Critical Care Medicine, Sleep Disease Medical Center, The Affiliated Hospital of Jianghan University, Wuhan, 430000 Hubei, China.ORCID https://orcid.org/0000-0002-8411-7112
Medical Center Hospital · USWuhan Sixth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PAH) is a proliferative disease of pulmonary blood vessels, but the pathogenesis of pulmonary hypertension is still unclear. This article explores the role of tumor necrosis factor-

Indexed as

Hypertension, PulmonarySildenafil CitrateThromboplastinTumor Necrosis Factor-alphaAnimalsBlood CoagulationDisease Models, AnimalDrug CarriersMonocrotalineNanoparticlesPulmonary ArteryRatsDrug CarriersMonocrotalineSildenafil CitrateThromboplastinTumor Necrosis Factor-alpha

Identifiers

PMID35602350
PMCPMC9122730
OpenAlexW4280635832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.